Doctor of Medicine, University of Witwatersrand. More than 20 years of experience in the scientific, clinical, operational, and commercial aspects of the biological/pharmaceutical business. Formerly with Novartis, responsible for helping increase the North American oncology revenues to over US$ 2.1 billion from approximately US$ 50 million in 10 years. 2005, joined Millennium; currently, Chief Executive Officer and President, Millennium: The Takeda Oncology Company, responsible for driving growth and overall performance in discovering, developing, and commercializing new treatments for cancer while developing its iconic talent and culture as the company progresses. Recipient of awards: Woman of the Year, Healthcare Businesswomen's Association (2009); Innovator of the Year Award, Massachusetts BIO Organization (2011).